Study Overview: This study is looking at a special guiding system to help people with diabetes who use insulin injections manage their insulin doses. The study lasts for about 8 to 10 weeks, including a 2 to 4-week practice period and a 6-week study period.
Eligibility: Participants should be aged 6 to 75 years and have Type 1 or Type 2 diabetes for at least 6 months. They must use or plan to use basal insulin and have an HbA1c level of 11% or lower. They need to be comfortable using a continuous glucose monitor (CGM) and a smartphone for tracking their diabetes management.
Exclusion Criteria: People with serious health issues like certain kidney or eye problems, pregnant women, or those with conditions affecting their ability to participate safely cannot join. Participants also cannot be part of another study or use certain types of insulin.
- Involves 8 to 10 weeks with a few study visits.
- Participants must use a smartphone and CGM.
- Must have stable diabetes and not currently pregnant.